Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
CytoSorbents to Present at the Cowen 41st Annual Health Care Conference
-
CytoSorbents Reports Record Third Quarter 2020 Financial Results
-
CytoSorbents Reports Record Second Quarter 2020 Financial Results
-
Cytosorbents (CTSO) Prices 5.26M Common Share Offering at $9.50/Sh
-
CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common Stock
-
Cytosorbents (CTSO) Announces Proposed $40 Million Public Offering of Common Stock
-
CytoSorbents Corporation Announces Proposed $40 Million Public Offering of Common Stock
-
Cytosorbents (CTSO) CEO to Discuss COVID-19 Pandemic and its CytoSorb Treatment of Cytokine Storm
-
CytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today
-
CytoSorbents to Report Fiscal 2019 Operating and Financial Results and to Present at Cowen 40th Annual Healthcare Conference
-
CytoSorbents (CTSO) PT Lowered to $11.50 at Cowen
-
CytoSorbents to Present at the Cowen 39th Annual Health Care Conference
-
CytoSorbents (CTSO) PT Raised to $15 at Cowen
-
CytoSorbents (CTSO) PT Raised to $13 at Cowen
-
CytoSorbents (CTSO) PT Raised to $11 at Cowen
-
CytoSorbents to Present at the 38th Annual Cowen Healthcare Conference
-
CytoSorbents (CTSO) PT Raised to $9 at Cowen
-
CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017
-
UPDATE: Cowen Starts CytoSorbents (CTSO) at Outperform
-
Cytosorbents (CTSO) Tops Q1 EPS by 5c
-
CytoSorbents Reports First Quarter 2017 Financial Results
-
CytoSorbents 2017 - Propelling the Company to the "Next Level"
-
Cytosorbents (CTSO) Prices 2.22M Share Follow-On Offering at $4.50
-
CytoSorbents Announces Pricing of Follow-On Offering
-
Cytosorbents (CTSO) to Offer Common Stock
-
CytoSorbents Announces Proposed Offering of Common Stock
-
CytoSorbents Reports Record Quarterly and Full-Year 2016 Revenue
-
CytoSorbents to Present at 37th Annual Cowen and Company Healthcare Conference

